EFSA

 

Forging stronger partnerships with member states

EFSA’s new Scientific Co-operation Roadmap intensifies collaboration with member states up to 2016, and marks a shift in focus towards increased knowledge sharing and intelligent use of expertise and resources. The roadmap sets out a risk assessment agenda of shared priorities with member states. The objectives are to share work programmes, create opportunities for scientific […]

Software tool for GM data analysis

New software from the European Food Safety Authority (EFSA) provides stakeholders with a tool for carrying out complex data analysis as part of the risk assessment of genetically modified (GM) plants. The user friendly program, which can be downloaded free of charge from EFSA’s website, allows stakeholders such as Member States and industry applicants to […]

,

Acrylamide in food is a public health concern, says EFSA draft

Based on animal studies, EFSA has confirmed previous evaluations that acrylamide in food potentially increases the risk of developing cancer for consumers in all age groups. Acrylamide in food is produced by the same chemical reaction that ‘browns’ food during everyday high temperature (+150°C) cooking in the home, catering and food manufacturing. European and national authorities […]

Softer stance on health claims

According to Innova Market Research, interest in healthy options appears to be continuing unabated. This is despite cutbacks in consumer expenditure and problems in some countries with regard to health claims legislation. Nearly 40% of the global launches recorded by Innova Market Insights in 2013 were positioned on a health platform of some kind, mainly […]

, ,

EFSA approves vitamin D2-rich yeast

The European Food Safety Authority (EFSA) has issued a positive scientific opinion on vitamin D2-rich baker’s yeast (Saccharomyces cerevisiae). This will allow manufacturers to use Lallemand Vita D yeast as a natural and vegetarian alternative source of vitamin D. Summer sunlight is the best source of vitamin D, but the food we eat plays an […]

,

EFSA consults on assessment of risks to human health

EFSA is launching a public consultation on its draft assessment of the human health risks posed by exposure to bisphenol A (BPA). The Authority has undertaken a comprehensive review of scientific literature and previous risk assessments from expert bodies on BPA. BPA is a chemical compound used in food contact materials such as packaging and […]

Oat beta-glucan wins award

DSM’s heart health ingredient OatWell oat beta-glucan has been named one of the most innovative products of the year at the Food Ingredients South America (FiSA) awards 2013. Beta-glucan, a soluble fibre found in oats, is a naturally-derived ingredient that is particularly well-known for its heart health benefits, and also helps to lower cholesterol and […]

, , ,

EU votes to ban ‘burnt, nutty’ flavour substance

The European Commission and European Union member states have this week declared that the flavouring substance 3-acetyl-2,5-dimethylthiophene should be banned. ‘The flavouring substance 3-acetyl-2,5-dimethylthiophene is genotoxic (that is, it can damage DNA, the genetic material of cells) and therefore a safety concern for human health. Genotoxic substances should not be intentionally added to the food […]

,

November date for aspartame opinion

EFSA and the European Commission have agreed to extend the timeframe for the full re-evaluation of aspartame, rescheduling it for November this year. The decision will, says the safety authority, allow it sufficient time to consider and address feedback, including new information, resulting from the public consultation on its draft opinion. From the comments received, […]

,

Campylobacter cases on the up, says EFSA report

Campylobacteriosis remains the most reported zoonotic disease in humans, with a continuous increase in reported cases over the last five years. However, Salmonella cases in humans have continued to fall, marking a decrease for the seventh consecutive year. Those are the main findings of the annual report on zoonoses and foodborne outbreaks in the European […]

,

EU agencies to advise on bute risk

The European Commission has asked EFSA and the European Medicines Agency (EMA) to carry out a joint assessment of the risks to human health from residues of the anti-inflammatory drug phenylbutazone in horsemeat. The request comes in the wake of the horsemeat scandal and the discovery of phenylbutazone – also known as ‘bute’ – in […]

,

Food and Drink Technology